title: Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
authors.forename: Onima
authors.initials: O
authors.lastname: Chowdhury
authors.forename: Abraham
authors.initials: A
authors.lastname: Varghese
authors.forename: Jonathon
authors.initials: J
authors.lastname: Pattinson
authors.forename: P
authors.initials: P
authors.lastname: Carrington
authors.forename: Adrian
authors.initials: A
authors.lastname: Bloor
authors.forename: George A
authors.initials: GA
authors.lastname: Follows
authors.forename: Peter
authors.initials: P
authors.lastname: Hillmen
authors.forename: Anna
authors.initials: A
authors.lastname: Schuh
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D057176:Compassionate Use Trials; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D006113:United Kingdom
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C527517:ofatumumab